BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF
1229 results:

  • 1. Clinical diagnosis and management of multiple cerebral ring-enhancing lesions-study of 50 patients at a tertiary healthcare center.
    Patel A; More B; Rege I; Ranade D
    J Cancer Res Ther; 2024 Jan; 20(1):112-117. PubMed ID: 38554307
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evidence for external beam radiotherapy in mediastinal Hodgkin and non-Hodgkin lymphoma - systematic review.
    Kowalska M; Sitarz-Kilian E; Jaros K; Koperny M; Moćko P; Siwiec J; Kawalec P
    Ann Agric Environ Med; 2024 Mar; 31(1):47-56. PubMed ID: 38549476
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Zishen Qingre Lishi Huayu recipe promotes proliferation and inhibits apoptosis of GCs of PCOS via KLF4-C/EBPβ pathway.
    Liu S; Xiao M; Jin J; Zhan X; Li X; Ren Y; Yu X; Liu T; Yi Y; Liang R; Peng J
    J Ethnopharmacol; 2024 Jun; 328():118027. PubMed ID: 38537844
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Describing patterns of familial cancer risk in subfertile men using population pedigree data.
    Ramsay JM; Madsen MJ; Horns JJ; Hanson HA; Camp NJ; Emery BR; Aston KI; Ferlic E; Hotaling JM
    Hum Reprod; 2024 Apr; 39(4):822-833. PubMed ID: 38383051
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Next Generation Sequencing Analysis of Fibrin-associated Large B-cell lymphoma Reveals Pathogenic Single Nucleotide Variants.
    DO J; Yenwongfai LN; DO SI; Na K
    Anticancer Res; 2024 Feb; 44(2):665-672. PubMed ID: 38307569
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management.
    Ong SY; Zain JM
    Am J Hematol; 2024 Mar; 99(3):439-456. PubMed ID: 38304959
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluating testicular tissue for future autotransplantation: focus on cancer cell contamination and presence of spermatogonia in tissue cryobanked for boys diagnosed with a hematological malignancy.
    Kourta D; Camboni A; Saussoy P; Kanbar M; Poels J; Wyns C
    Hum Reprod; 2024 Mar; 39(3):486-495. PubMed ID: 38227814
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Treatment of Richter's Transformation with Novel Therapies.
    Bajwa A; Habib A; Kittai AS
    Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma.
    Farnetani G; Vannucci M; Fino MG; Cioppi F; Rosta V; Palma M; Tamburrino L; Vinci S; Casamonti E; Degl'Innocenti S; Spinelli M; Abrardo C; Marchiani S; Lotti F; Muratori M; Riera-Escamilla A; Krausz C
    Hum Reprod; 2024 Mar; 39(3):496-503. PubMed ID: 38177083
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
    Tsilingiris D; Vallianou NG; Spyrou N; Kounatidis D; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Obes Rep; 2024 Mar; 13(1):1-34. PubMed ID: 38159164
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrative Approaches in the Treatment of Patients Affected by lymphoma.
    Levy Yurkovski I; Andreazzoli F; Ben-Arye E; Attias S; Tadmor T
    Curr Oncol Rep; 2023 Dec; 25(12):1523-1534. PubMed ID: 38060095
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Blinatumomab in Practice.
    Lantz J; Pham N; Jones C; Reed D; El Chaer F; Keng M
    Curr Hematol Malig Rep; 2024 Feb; 19(1):1-8. PubMed ID: 38060085
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell lymphoma : A Cost-Effectiveness Analysis.
    Kelkar AH; Cliff ERS; Jacobson CA; Abel GA; Dijk SW; Krijkamp EM; Redd R; Zurko JC; Hamadani M; Hunink MGM; Cutler C
    Ann Intern Med; 2023 Dec; 176(12):1625-1637. PubMed ID: 38048587
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel Biomarkers and Molecular Targets in ALL.
    De Sa H; Leonard J
    Curr Hematol Malig Rep; 2024 Feb; 19(1):18-34. PubMed ID: 38048037
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Novel therapies for pediatric acute lymphoblastic leukemia.
    Graff Z; Burke MJ; Gossai N
    Curr Opin Pediatr; 2024 Feb; 36(1):64-70. PubMed ID: 37991046
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pediatric acute myeloid leukemia - novel approaches.
    Karol SE; Gueguen G
    Curr Opin Hematol; 2024 Mar; 31(2):47-52. PubMed ID: 37982279
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Salt Behind the Scenes of Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Afsar B; Afsar RE
    Curr Nutr Rep; 2023 Dec; 12(4):830-844. PubMed ID: 37980312
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Practical challenges in lung cancer pathology: bedside care to treatment decisions.
    Takano AM; Chow CY; Lim KH
    Curr Opin Pulm Med; 2024 Jan; 30(1):48-57. PubMed ID: 37937545
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Measurable Residual Disease Monitoring in lymphoma.
    Cuzzo B; Lipsky A; Cherng HJ
    Curr Hematol Malig Rep; 2023 Dec; 18(6):292-304. PubMed ID: 37930608
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Towards development of biobetter: L-asparaginase a case study.
    Tripathy RK; Anakha J; Pande AH
    Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 62.